
Sep 21, 2026
Are Options Traders Betting on a Big Move in Journey Medical Stock?
Options traders appear to be anticipating a significant price movement in Journey Medical (DERM) stock, as indicated by the high implied volatility in recent options activity, particularly the September 18, 2026 $50.00 Call. Despite this, analysts currently rate Journey Medical as a Zacks Rank #4 (Sell) and have lowered earnings estimates, suggesting potential for a strategic options trade involving selling premium.
Company relevance
100.00%
Company sentiment
Bearish
Overall sentiment
Bearish